(Q45001844)

English

High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Koenigsmann M

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Mohren M

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Jentsch-Ullrich K

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Franke A

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Becker E

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Heim M

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Freund M

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Casper J

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

477-483

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Myeloablative conditioning regimens for AML allografts: 30 years later

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

The role of busulfan in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Treosulfan is an effective inducer of cell death in myeloma cell lines and primary myeloma cells from patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Antileukaemic activity of treosulfan in xenografted human acute lymphoblastic leukaemias (ALL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

High-dose etoposide phosphate and G-CSF mobilizes peripheral blood stem cells in patients that previously failed to mobilize

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Rituximab: enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

21 January 2018

Venoocclusive disease of the liver following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

7 January 2021

based on heuristic

inferred from DOI database lookup

Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab reduces relapse risk after allogeneic and autologous stem cell transplantation in patients with high-risk aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704626

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704626

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45001844&oldid=2207038497"